Clinical Trials

Improved outcomes for all when patients partner with researchers and doctors.

Clinical Trials

Our specialist trials consulting clinic is located at the Lismore Base Hospital:

North Coast Cancer Institute
70-72 Hunter Street
Lismore NSW 2480

Phone: (02) 6629 4559 or (02) 6629 4438
Hours: 8:30am – 4:30pm Monday to Friday

Clinical Trials

OPEN FOR RECRUITMENT 

HLX43

An Open-label, Multi-center, Global Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

Click here for inclusion criteria

REGENERON 2208

A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants with Resectable Stage 3 or 4 Melanoma

Click here for inclusion criteria

ELEGANT

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.

Click here for inclusion criteria

 

CLOSED TO RECRUITMENT

Regeneron Adjuvant – Harmony
Latify
Keynote 630
Aphinity

Keynote 629
Embark
NivoPass
Monarch E  

Clinical Trials Links

There are a number of clinical trials underway for patients with cancer. To find out about current clinical trials in Australia you can go to the Australian Clinical Trials website